You can get a GLP-1 prescription from an app for about $99 a month, and if a prescription is genuinely all you need, that may be the right call. We would rather answer the question honestly than talk you out of it. People ask us, plainly, why pay for a membership when you just want a prescription, and the honest answer is this: a prescription adjusts appetite. It does not tell you why the weight returned after every diet, why a plateau arrived at a high dose, or why nobody has looked at your labs since the medication began. Our medical weight loss program starts with the labs and the clinician; the prescription follows when it is indicated.
- A prescription adjusts appetite; a diagnosis explains why weight, blood sugar or hormones moved in the first place.
- 12% of US adults were taking a GLP-1 in late 2025 and 18% had ever taken one; 17% of ever-users got the drug from an online provider (KFF, November 2025).
- The $299 fee is the same at every dose; medication is billed by your pharmacy at the pharmacy's own price, with nothing added by us.
- Nothing here is compounded: Wegovy, Zepbound, Ozempic and Mounjaro are branded, FDA-approved options, prescribed only when labs support them.
- If a clinician cannot accept you into care, the $598 hold is released and you are never charged.
The question, in your words
You have done the math already. A telehealth app charges about $99 a month, takes a questionnaire, and a prescriber you will never meet signs. You get the medication and you get on with your life. So why pay $299 a month plus a $598 start for what sounds like the same outcome?
It is a fair question, and it deserves a fair answer rather than a slogan. The two offers are not the same product at different prices. One sells a prescription. The other buys a diagnosis, a clinician who reads your results against your history, and a protocol that is revisited every 90 days. Whether the second one is worth it depends entirely on whether you want the first one to actually work.
What a prescription alone gives you, honestly
A GLP-1 medication lowers appetite and slows gastric emptying, and for most people it does exactly that. If your only goal is a lower number on the scale and you already understand your own metabolic picture, a prescription-only service delivers it.
There are things it does not deliver, and they are not marketing points; they are gaps you will feel later.
- No baseline labs in most cases, so nobody knows your A1c, fasting insulin, ApoB or thyroid function before the medication starts.
- No one to ask why the scale stalled at week fourteen, or why a dose that worked in month two stopped working in month six.
- No follow-up on the side effects that made you reduce your own dose, because the prescriber sees a dashboard, not you.
- No record that follows you if you move, switch jobs or travel for a season.
None of that shows up on day one. It shows up around month four, when the medication is still in your fridge and the questions have nowhere to go.
What the $99 app never tests
The KFF Health Tracking Poll fielded in late October and early November 2025 found that 12% of US adults were taking a GLP-1 and 18% had ever taken one. Most got the drug from a primary care doctor or a specialist; 17% got it from an online provider. Among ex-users, cost was the most common reason they stopped (14%), followed by side effects (13%). Both of those are reasons a clinician is supposed to catch, which is the part a prescription-only service structurally cannot provide.
The FDA resolved the semaglutide and tirzepatide shortages in late 2024 and early 2025, which closed the legal door on the mass compounding those $99 prices were built on. The apps that remain cheap are cheap because there is no clinician, no labs and no follow-up behind the signature. The FDA's own guidance on that transition is public: see the agency's policies for compounders as supply stabilized.
What the membership actually does with the prescription
Here is the part people do not expect. When you arrive already on a GLP-1, nothing is interrupted. You tell us what you take, at what dose, and who prescribes it. Your baseline panel is drawn within days: complete blood count, comprehensive metabolic panel, hemoglobin A1c, lipid panel, ApoB, Lp(a), TSH, hs-CRP and fasting insulin. Then a clinician reads it with you and says plainly what continues, what changes and why.
Our medical director's rule is simple and it is in the protocol: we do not automatically increase a GLP-1 every month because the dosing schedule says another dose exists. Improvement sometimes means taking something away, not adding more. That is only possible when someone is actually watching your markers instead of your refill history.
One flat fee for the doctor. Zero markup on the medicine.
If the labs say a GLP-1 is indicated, branded, FDA-approved medication is prescribed to the pharmacy you choose. We earn nothing on the medication, which is the only reason we can say the fee never rises with the dose. The structure behind that claim is described in Aligned Medicine and the zero-markup model.
The two charges, plainly
Two separate charges: the clinician and the pharmacy
| What | How it is charged | What it buys |
|---|---|---|
| The clinician | $598 held at sign-up, covering the first two months, then $299 a month | Quarterly Biomarker Audit, the clinical intake, video visits, asynchronous messaging with the care team, month-to-month after month two |
| The medication | Billed by the pharmacy you choose, at that pharmacy's own price | The branded drug itself, nothing added, no molecule upcharge, no dose upcharge |
Two charges, one decision each. The fee never changes with your prescription or your dose. The pharmacy charge is set by the pharmacy, and where your insurance covers a branded drug, that coverage applies to the prescription as usual. Where it does not, the manufacturers' own self-pay prices are the ones you would pay anywhere: Wegovy pens were $199 a month for the first two fills through NovoCare in September 2026 and $349 a month after, and Zepbound vials were $299 to $449 a month through LillyDirect depending on dose. Those are the manufacturers' published prices with their dates, not ours to change.
Why the fee does not flex with the dose
The flat fee is not a pricing trick. It is the answer to the problem this page opened with. A service that makes money on the medication has a reason to escalate the dose and a reason not to ask why a plateau happened. A service that earns the same $299 whether you are on the starting dose or the top dose has a reason to find the lowest dose that works and keep you there.
Your clinician's cadence is: baseline panel in your first days, a quarterly panel every 90 days with the markers treatment is expected to move, and a full reassessment at six and twelve months. The question at each visit is whether the treatment is still earning its place.
When a prescription alone is enough
We will say this plainly because it is true. If you have had comprehensive labs within the last year and they were read with you, if you understand your own metabolic picture, and if you want nothing more than the medication, a $99 app may be the right tool and we would rather lose the sale than pretend otherwise.
The membership is built for a different reader: the person who wants to know why the weight came back after every diet, why the plateau happened at a high dose, or why fatigue and brain fog traveled with the weight gain. If that is the question you actually have, a prescription is not the answer to it, and the diagnosis is.
It is also not for anyone who wants compounded medication, research peptides, or a prescription with no labs at all. Not everyone is accepted into care, and if a clinician cannot accept you, the $598 hold is released and you are never charged and a person tells you why. Once accepted, the first two months are non-refundable, because that is the month that diagnoses and the month that treats.
What the first two months look like
- Week one. The eligibility check, the intake, and the $598 checkout that covers months one and two.
- Week one to two. Your lab draw through our national lab network, booked for you, fasting in the morning, about fifteen minutes.
- Day 9 to 13. Results in your portal, each marker explained in plain English before your visit.
- Inside month one. A video visit with your clinician: what continues, what changes, and your protocol.
- Month two. Treatment begins where it is indicated: branded medication to your pharmacy at its own price, or hormone or thyroid therapy where the labs and the history call for it.
FAQ
Why would I pay $299 a month when I can get a GLP-1 prescription online for about $99? Because a prescription adjusts appetite and a diagnosis explains why weight, blood sugar or hormones moved in the first place. The $99 app sells the drug and tests nothing; the membership draws a comprehensive panel every 90 days and reads it with you, and the fee never rises with the dose.
Will I have to stop my current GLP-1 and start over? No. Bring your prescription and any labs you have. The baseline panel is drawn within days and your clinician decides with you what continues, what changes and why. There is no forced restart.
Does the membership fee include the medication? No, and nothing is marked up. Medication is prescribed to the pharmacy you choose at that pharmacy's own price. The fee and the pharmacy bill are two separate charges, always.
What does the $598 first charge cover? One charge, two months: the month that diagnoses and the month that treats. Never charged if a clinician cannot accept you into care; non-refundable once you are accepted. From month three it is $299 a month, cancel anytime.
Can I pay with an HSA or FSA? We don't promise the membership fee is HSA or FSA eligible; your account administrator decides, so check with them before using those funds.
Do I have to get my labs at a specific place? The quarterly panel is drawn at Quest Diagnostics, booked for you within days of joining. More than 2,000 locations, a morning draw, fasting 8 to 12 hours, water encouraged.
What if a prescription is genuinely all I want? Then a $99 app may be the right tool and we would rather say so than keep you. What you give up is the diagnosis, the quarterly markers, and a clinician who stays.
One last thing
The clearest tell in this whole market is who benefits from your dose going up. Ask any provider the direct question: does your revenue change if my dose escalates? If the answer is anything other than no, the escalation is the business model, and every page of fine print will eventually confirm it.
Related reading
- Medical weight loss, prescribed on labs, not on hope
- Best GLP-1 medications for weight loss in 2026
- Are telehealth weight loss programs effective?
- What the $598 start charge actually covers
References
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. 2026. www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
- KFF Health Tracking Poll, October-November 2025: Prescription Drug Costs and GLP-1 Use. 2025. www.kff.org/public-opinion/kff-health-tracking-poll-prescription-drug-costs-views-on-trump-administration-actions-and-glp-1-use